Decentralized Clinical Trials: What Biotechs Need to Know
The buzz around decentralized clinical trials, or DCT, has captured the attention of organizations across the clinical research industry, prompting no small degree of excitement, apprehension, and speculation. DCT has some in the industry cheering, some biting their nails, and others scratching their heads. But what exactly does DCT mean—and will it truly change clinical research?